Abstract
Cardiolipin (CL) is a universal component of energy generating membranes. In most bacteria, it is synthesized via the condensation of two molecules phosphatidylglycerol (PG) by phospholipase D-type cardiolipin synthases (PLD-type Cls). In the plant pathogen and natural genetic engineer Agrobacterium tumefaciens CL comprises up to 15% of all phospholipids in late stationary growth phase. A. tumefaciens harbors two genes, atu1630 (cls1) and atu2486 (cls2), coding for PLD-type Cls. Heterologous expression of either cls1 or cls2 in Escherichia coli resulted in accumulation of CL supporting involvement of their products in CL synthesis. Expression of cls1 and cls2 in A. tumefaciens is constitutive and irrespective of the growth phase. Membrane lipid profiling of A. tumefaciens mutants suggested that Cls2 is required for CL synthesis at early exponential growth whereas both Cls equally contribute to CL production at later growth stages. Contrary to many bacteria, which suffer from CL depletion, A. tumefaciens tolerates large changes in CL content since the CL-deficient cls1/cls2 double mutant showed no apparent defects in growth, stress tolerance, motility, biofilm formation, UV-stress and tumor formation on plants.
Introduction
Bacterial cytoplasmic membranes consist of various lipids with distinct chemical and physical properties. They are arranged in a two-dimensional matrix with proteins embedded, thus allowing selective transport, sensing, communication and energy-generating processes. The most abundant prokaryotic membrane lipids are the glycerophospholipids phosphatidylethanolamine (PE), phosphatidylglycerol (PG) and cardiolipin (CL). CL is an anionic phospholipid with varying amounts in bacterial membranes. Despite its low abundance during exponential growth, CL influences diverse physiological processes, such as localization and stability of proteins and protein complexes, formation of membrane microdomains and the generation of membrane potential [1–5]. The molecular structure of CL is unique. Due to its four acyl chains and a small hydrophilic headgroup, CL displays a cone-shaped architecture and preferably locates at regions of negative membrane curvature [6–8].
In many bacteria, CL helps to withstand environmental stresses. Escherichia coli accumulates CL when cells are exposed to high salinity and CL mediates localization and activity of the osmosensory transporter ProP [2]. Temperature-dependent CL synthesis has been documented for Bacillus subtilis under hypoxic conditions [9]. In Staphylococcus aureus, prolonged survival under high-salinity conditions depends on the presence of CL [10]. In Rhodobacter sphaeroides, CL deficiency leads to altered cell morphology and negatively affects biofilm formation [11]. However, despite its broad impact on cell physiology, CL does not appear to be essential for bacterial survival, since loss of CL mostly results in rather mild phenotypes.
Many bacteria harbor multiple genes coding for possible CL synthases (Cls) suggesting genetic redundancy [12]. E. coli harbors three Cls paralogues encoded by clsA, ybhO (clsB) and ymdC (clsC) [13]. In B. subtilis, three homologues to E. coli clsA have been identified, termed ywnE (clsA), ywjE, and ywiE [7]. CL synthesis in S. aureus is mediated by the gene products of cls1 and cls2 [14].
Traditionally, CL biosynthesis pathways were classified as either eukaryotic or prokaryotic. The most prevalent eukaryotic pathway is driven by CDP-alcohol phosphatidyltransferases (CAP-type Cls) and involves the condensation of PG with cytidine diphosphate-diacylglycerol (CDP-DAG) to form CL. In contrast, the transphosphatidylation between two PG molecules via Cls enzymes of the phospholipase D superfamily (PLD-type Cls) has been considered as a hallmark of prokaryotic CL synthesis. However, recent findings suggest that the classification into eukaryotic and prokaryotic CL biosynthesis pathways is not appropriate anymore as enzymes with characteristics of eukaryotic Cls have been identified in some prokaryotes and vice versa. Phylogenetic analysis revealed a large number of unicellular eukaryotes containing putative PLD-type Cls [12]. At the same time, bacterial Cls utilizing PG and another molecule for CL biosynthesis rather than two PG molecules have been discovered. Sco1389 from Streptomyces coelicolor was the first bacterial Cls identified to use CDP-DAG as a phosphatidyl donor in CL synthesis [15]. The bifunctional PLD-type Cls (Xc_0186) of Xanthomonas campestris is able to use CDP-DAG and PG for CL production and CDP-DAG and ethanolamine for PE synthesis [16]. E. coli ClsC catalyzes CL formation by a transesterification reaction between PE and PG, thus representing yet another pathway for CL biosynthesis [13].
In the phytopathogenic soil bacterium Agrobacterium tumefaciens CL accumulates to up to 15% of the total phospholipids in late stationary phase. Apart from the common bacterial phospholipids PE, PG and CL, A. tumefaciens contains the methylated PE derivatives monomethyl-PE, dimethyl-PE and PC. Additionally, it produces two phosphorus-free ornithine lipids (OL1/2) and under phosphate deprivation different glycolipids and diacylglycerol trimethylhomoserine (DGTS) [17, 18]. A. tumefaciens is widely known for its ability to cause crown gall tumors upon infection of plant tissues. Tumorigenesis is based on the transfer of a small part of bacterial DNA, the T-DNA, via the type IV secretion system (T4SS) into the plant cell [19]. Tumor formation strongly correlates with the membrane phospholipid composition. PC is required for host-microbe interaction whereas the absence of ornithine lipids stimulates tumor formation [18, 20]. These findings raised the question of whether CL plays a role in Agrobacterium physiology and virulence. Therefore, we set out to identify CL biosynthesis enzymes and to examine their physiological importance in A. tumefaciens.
Materials and Methods
Bacterial strains, plasmids and growth conditions
The strains, plasmids and oligonucleotides used in this study are listed in S1 Table and S2 Table. If not stated otherwise, Escherichia coli, Agrobacterium tumefaciens C58 and derivative cls mutant strains (Δcls1, Δcls2 and Δcls1/Δcls2) were grown in LB medium [21] supplemented with kanamycin (50 μg/ml), ampicillin (100 μg/ml) or tetracycline (10 μg/ml) if appropriate. E. coli DH5α was used for cloning procedures. E. coli BL21 (DE3) served as a host for the overproduction of Cls1 and Cls2 from the corresponding pET24b-based expression plasmids. Growth temperature was 37°C for E. coli strains and 30°C for A. tumefaciens strains if not stated otherwise. For the induction of the virulence cascade, A. tumefaciens was grown to an OD600 of 0.2 in AB medium (pH 5.5, supplemented with 1% (w/v) glucose) [22] prior to the addition of acetosyringone (Sigma-Aldrich, St. Louis, MO, USA) to a final concentration of 0.1 mM. Cells were further incubated for 18 h at 23°C.
Plasmid construction
Recombinant DNA work was carried out according to standard protocols [21]. For the heterologous expression of A. tumefaciens cls1 and cls2 in E. coli both genes were PCR amplified using chromosomal DNA as a template and the designated primers S2 Table). The PCR products were digested with the engineered restriction sites NdeI and XhoI and cloned into the expression vector pET24b, resulting in pBO3712 and pBO3713. For promoter activity analysis, PCR-generated fragments of the expected promoter regions of cls1 (280 bp) and cls2 (465 bp) were digested with KpnI and XhoI and ligated into pAC01 treated with the same enzymes resulting in pBO1256 and pBO3732. Chromosomal deletions of cls1 and cls2 were created as previously described using the suicide vector pK19mobsacB [18]. For the construction of the respective plasmids, 400–500 bp fragments up- and downstream of cls1 and cls2 were amplified using the designated primer pairs (S2 Table). PCR products of the upstream regions were digested with EcoRI and PstI and cloned into the vector pK19mobsacB, resulting in the plasmids pBO1254 (pK19mobsacB_cls1_up) and pBO1255 (pK19mobsacB_cls2_up). PCR-generated fragments of cls1 and cls2 downstream regions were digested with PstI and HindIII and ligated into pBO1254 and pBO1255, respectively, resulting in pBO1270 (pK19mobsacB_cls1_up_down) and pBO1271 (pK19mobsacB_cls2_up_down). For the complementation of the cls deletion strains, cls1 (1577 bp) and cls2 (1481 bp) coding regions were cloned into the pBBSyn vector, using the restriction sites XbaI and SacI, resulting in pBO3723 and pBO3724. Expression of cls1 and cls2 was under the control of the strong constitutive Psyn promoter. The correct nucleotide sequences of all generated plasmids were confirmed by automated sequencing. Plasmids were transferred into E. coli via transformation using heat shock and into A. tumefaciens via electroporation.
Construction of cls deletion mutants
Chromosomal deletions of cls1 and cls2 were engineered using the plasmids pBO1270 and pBO1271, which cannot replicate in A. tumefaciens. Both constructs were transferred into A. tumefaciens via electroporation. Kanamycin-resistant clones should have integrated the plasmids by a first recombination event and were cultivated for 18 h in LB medium. Different dilutions (10−2, 10−3 and 10−4) were plated on LB agar plates containing 10% (w/v) sucrose. Double cross over events resulted in sucrose tolerant and kanamycin sensitive clones. Double deletion of cls genes was achieved using the cls1 single deletion strain as a background for mutagenesis of cls2 in an analogous manner. Sucrose-resistant and kanamycin-sensitive clones were analyzed using PCR and Southern blot analysis [21].
Overproduction of Cls1 and Cls2 in E. coli
For the overexpression of cls1 and cls2 in E. coli, pBO3712 and pBO3713 were transferred into E. coli BL21(DE3) and plated on LB agar containing kanamycin. After incubation for 18 h at 37°C, single colonies were transferred into fresh LB medium with kanamycin and incubated overnight. Cells were again transferred into fresh medium containing kanamycin to a start OD580 of 0.1. Protein synthesis was induced with 0.4 mM IPTG (isopropyl-β-d-thiogalactopyranoside) at an OD580 of 0.6 for 3 h at 30°C. Equal amounts of cells were harvested and protein and lipid samples were further processed.
In vitro activity of Cls1 and Cls2 in Agrobacterium crude extracts
A. tumefaciens wild type and cls deletion strains were grown in LB medium for 18 h at 30°C. 30 ml of cells were harvested, washed and resuspended in 3 ml Tris/HCl buffer (50 mM Tris, 50 mM NaCl, pH8). Cell lysis was achieved by French Press (three passes, 900 psi). 100 μl of reaction mixture contained 300 μg of total protein, 0.4 mM of the respective potential lipid substrate(s) (PE, PG, CDP-DAG, CL,18:1) and 0.02% Triton X-100. Samples were incubated for 12 hours at 30°C before lipids were extracted according to Bligh and Dyer [23] and analyzed via one-dimensional thin layer chromatography (1D-TLC) as described below.
Lipid analysis by TLC
Phospholipids of A. tumefaciens or E. coli strains were isolated according to Bligh and Dyer [23]. Briefly, 1 to 2 ml of culture were harvested by centrifugation, washed with 500 μl of water to remove residues of medium and resuspended in 100 μl of water. 375 μl of a mixture of methanol:chloroform (2:1) was added and samples were homogenized before 100 μl of water and 100 μl of chloroform were added. Samples were briefly vortexed and centrifuged for 5 minutes at 13.000 rpm. The lower organic phase was collected and dried under vacuum. The lipid pellet was resuspended in 15 μl of methanol:chloroform (1:1) and spotted onto a HPTLC silica gel 60 plate (Merck, Darmstadt, Germany). For 1D-TLC a mixture of n-propanol:propionate:chloroform:water (3:2:2:1) was used as a running solvent. For two-dimensional TLC (2D-TLC), mixtures of chloroform:methanol:water (65:25:4) and chloroform:methanol:acetic acid:water (90:15:10:3,5) were used as running solvents for first and second dimension, respectively. For the visualization of the lipids, plates were sprayed with molybdenum blue reagent (Sigma-Aldrich, St. Louis, MO, USA) or charred after CuSO4-treatment at 180°C. Purified phospholipid standards (bovine heart cardiolipin, 1,2-dioleoyl-sn-glycero-3-phospho-rac-(1-glycerol), L-α-phosphatidylethanolamine) were purchased from Merck (Darmstadt, Germany).
Lipid analysis by gas chromatography MS
Lipids were isolated, separated and analyzed as previously described [17, 24]. Briefly, cells were grown in rich medium to early stationary phase before lipids were isolated and separated using 2D-TLC as stated above. Gas chromatography (GC) MS was used to quantify their fatty acid methyl esters.
Western blotting
For protein analysis, 1 ml of A. tumefaciens or E. coli cells was harvested and resuspended in SDS loading buffer in relation to the final OD580 (E. coli) or OD600 (A. tumefaciens). An OD value of 1 thereby equaled 100 μl SDS loading buffer. Samples were heated to 95°C for 10 min before equal amounts of extracts were separated by sodium dodecyl sulfate (SDS)-12,5%-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blot analysis using anti-Penta-His antibody (Qiagen, Hilden, Germany) and chemiluminescence detection (ECL). Detection of VirB8 and VirB9 was achieved using A. tumefaciens specific antisera (VirB8: 1/100.000; VirB9: 1/10.000).
Potato disc infection assay
Quantitative tumorigenesis assays with potato tuber discs were carried out as described before [25]. Briefly, A. tumefaciens was grown to an OD600 0.9–1.0 in rich medium, harvested via centrifugation and resuspended in phosphate-buffered saline at 108 and 106 cells/ml for inoculation. Potatoes were peeled and disinfected by immersing in 0.625% sodium hypochlorite before discs of approximately 0.4 cm thickness were cut from cylinders. The discs were placed on water agar and infected with 10 μl of bacterial suspensions (108 and 106 cells/ml). Petri dishes were sealed and incubated at 23°C for two days. The discs were then placed on water agar supplemented with 100 μg/ml ticarcillin to kill bacteria and incubated at 23°C for three weeks before tumors were counted.
β-Galactosidase assays
The β-galactosidase activity of A. tumefaciens cells transformed with pBO1256 and pBO3732 grown with ampicillin and tetracycline in LB medium or LB medium with additional 0.4 M NaCl was quantified according to standard protocols [26]. The plasmid pAC01 containing the promoterless lacZ gene was used as the negative control.
Results and Discussion
Agrobacterium tumefaciens encodes two putative cardiolipin synthases
Using the protein sequences of well characterized cardiolipin synthases (Cls) of the PLD- and CAP-type as query, we identified two open reading frames (atu1630 and atu2486) on the circular chromosome of A. tumefaciens, encoding PLD-type Cls homologs. On the basis of our functional analysis (see below) and in the order of their chromosomal location, we renamed atu1630 to cls1 and atu2486 to cls2. The cls1 gene codes for a polypeptide with a predicted molecular mass of approximately 58 kDa. With about 54 kDa, the translated open reading frame of cls2 is slightly shorter. The deduced Cls1 and Cls2 proteins display only about 23% sequence identity (data not shown) whereas Cls1 is about 41% identical to ClsC from E. coli (Fig 1A). Cls2 displays moderate sequence identities to the housekeeping Cls of E. coli (ClsA; ~ 27%) and S. aureus (Cls2; ~ 25%) as predicted by Clustal 2.1 (Percent Identity Matrix) [27]. The S. aureus and E. coli enzymes most likely use two PG molecules for CL synthesis and represent generic PLD-type cardiolipin synthases [14, 28]. A. tumefaciens Cls1 and Cls2 contain two HKD-motifs characteristic for enzymes of the phospholipase D (PLD) superfamily (Fig 1B). This group contains both eukaryotic and prokaryotic enzymes of phospholipid synthesis and modification [29, 30]. The highly conserved amino acids of the HKD-motifs [HXK(X)4D(X)6G(X)2N] are crucial for enzyme activity [13, 16, 31] and are thought to form a single active site [32]. Additionally, A. tumefaciens Cls1 harbors one N-terminal transmembrane domain (TMD, residues 1 to 24) whereas Cls2 features two TMDs (residues 4 to 26 and residues 39 to 61), as predicted by TMHMM software [33, 34]. According to these predictions, the active sites of Agrobacterium Cls1 and Cls2 face the periplasmic side of the membrane. This also holds true for the B. subtilis and R. sphaeroides Cls (data not shown) and has been proposed for S. aureus and E. coli Cls enzymes [14, 35]. Thus, a periplasmic active side might be a common feature of PLD-type Cls. Like A. tumefaciens Cls1 and Cls2, many bacterial Cls contain two (S. aureus Cls2, B. subtilis ClsA and E. coli ClsA) or three (B. subtilis YwiE) putative TMDs. However, the membrane associated E. coli ClsB and ClsC proteins lack TMDs and might represent peripheral Cls [13].
Agrobacterium cls1 and cls2 encode functional cardiolipin synthases
To provide evidence that A. tumefaciens cls1 and cls2 encode active Cls, both genes were heterologously expressed in E. coli BL21(DE3) as C-terminally His-tagged variants. Synthesis of both proteins with calculated molecular masses of approximately 59 kDa (Cls1) and 55 kDa (Cls2) was confirmed by Western blotting analysis (Fig 2A).
During logarithmic growth E. coli produces marginal amounts of CL as a result of low expression of clsA, whose product is responsible for the most part of CL production [13, 36]. Thus, we analyzed Cls1 and Cls2 activity in E. coli during logarithmic growth by two-dimensional thin-layer chromatography (2D-TLC). In contrast to the strain containing the empty vector (EV), strains expressing cls1 or cls2 produced notable amounts of CL (Fig 2B, lower panel) providing evidence that cls1 and cls2 encode functional Cls.
Attempts to purify Cls1 and Cls2 failed due to formation of inclusion bodies, which impeded in vitro biochemical characterization of the enzymes. Removal of the N-terminal putative TMD of Cls1 did not improve protein solubility (data not shown). However, the truncated Cls1 variant was still active (S1 Fig), demonstrating that the putative membrane-spanning region is not crucial for Cls1 activity. Likewise, TMDs of the Enterococcus faecium S44 and of the E. coli Cls enzymes are dispensable for enzyme activity and membrane association [37–39]. It has been proposed that the N-terminal TMDs in PLD-type Cls enzymes are cleaved off during maturation [38, 39], but their precise role remains unknown.
An Agrobacterium tumefaciens cls1/cls2 double mutant is deficient in CL formation
To investigate the physiological role and contribution of Cls1 and Cls2 to CL synthesis in A. tumefaciens, we constructed isogenic cls1 and cls2 single deletion strains (Δcls1 and Δcls2) and a double mutant (Δcls1/Δcls2). The lipid profiles of stationary phase wild type and cls mutant strains were investigated by 2D-TLC (Fig 3). As previously shown, A. tumefaciens wild type contained the phospholipids PE, PG and CL, the methylated PE-derivatives monomethyl-PE (MMPE) and PC as well as the ornithine lipids OL1 and OL2 (Fig 3, upper left panel) [17, 18]. The lipid profiles of the single cls1 and cls2 mutants resembled that of the wild type, suggesting that Cls1 and Cls2 act redundantly in CL synthesis (Fig 3, lower panel). The double mutant lacked detectable amounts of CL (Fig 3, upper right panel) suggesting that Cls1 and Cls2 are responsible for CL formation in A. tumefaciens. Expression of plasmid-encoded cls1 or cls2 restored CL accumulation to wild-type-like levels (S2 Fig). As mentioned above, A. tumefaciens Cls1 shares the highest sequence identity with the E. coli ClsC (41%; Fig 1A) which utilizes PE and PG for CL formation. Interestingly, ClsC activity is dependent on its neighboring gene ymdB which is unique among Cls [13]. The role of YmdB (a regulator of RNase III cleavage) [40] in CL formation still remains obscure. The ymdB-clsC operon seems to be conserved in some E. coli-related bacteria [13]. However, A. tumefaciens lacks a YmdB homolog and Cls1 does not seem to require an additional factor for its activity.
For a more detailed analysis of the membrane composition of the different A. tumefaciens cls mutant strains, we conducted quantitative GC/MS analysis (Fig 4). Lipid species were characterized by the quantification of fatty acid methyl esters as previously described [17, 24]. Overall lipid profiles from early stationary phase cls single mutants were similar to the wild type, confirming the results obtained by TLC analysis (Fig 4A). The quantities of the different phospholipids and OLs were consistent with previous reports [20, 41]. In the wild type, PE and PG make up to ~ 50% of total lipids. While PC accounts for ~ 20%, its precursor lipid molecule MMPE is found in smaller amounts (around 10%). The phosphorus-free lipid OL1 accounts for around ~ 15% of total lipid while its hydroxylated derivative OL2 occurs only in traces. The CL content reaches up to ~ 5% in A. tumefaciens wild type under the tested conditions (Fig 4A). The double mutant displayed slightly decreased PE and OL1 content and barely detectable amounts of CL (~0.2%) compared to the wild type and the single mutants. The residual CL in the double mutant might be explained by additional not yet identified Cls or promiscuity of other phospholipid synthases. Similarly, minor CL amounts (~0,5%) are still detected in R. sphaeroides cls mutant [42].The PG levels were substantially increased in the A. tumefaciens cls1/cls2 mutant (Fig 4A) supporting its role as precursor for CL formation by Cls1 and Cls2. Similar shift in phospholipid content have been documented in cls mutants of other organisms, such as Saccharomyces cerevisiae, S. aureus and E. coli [10, 13, 43].
We further investigated whether the loss of tetraacylic CL affects the fatty acid profile of A. tumefaciens. As illustrated in Fig 4B, the membrane lipid fatty acid composition of all strains was comparable to the wild type and contained primarily saturated or mono-unsaturated acyl chains. 18:1 was the most common fatty acid in all strains followed by 19:0 cyclopropane (19:0c) and 16:0 fatty acids. Altogether, they accounted for more than 90% of total fatty acids. Additionally, small amounts of mono-unsaturated 16:1 and 17:0 cyclopropane (17:0c) could be detected (< 5%). 18:0 and 18:1-Me were only present in traces. These numbers are well in line with previous reports [17] and imply that the composition of fatty acids in A. tumefaciens membrane lipids is not influenced by the loss of CL. This is in contrast, to the situation in Streptococcus mutans where loss of CL results in elevated levels of saturated fatty acids at the expense of unsaturated fatty acids [44].
Assuming that Cls1 and Cls2 might produce CL species with different fatty acid composition, we took a closer look at the CL-specific fatty acids in the wild type and the cls single mutants (Fig 4C). In the wild type, about 60% of fatty acids were mono-enoic fatty acids with 18 carbons followed by ~ 25% of unsaturated 16:0. 16:1 and 19:0c accounted for less than 10%. A similar CL fatty acid distribution was found in the individual cls1 and cls2 mutants suggesting that both enzymes produce similar CL products by using the same pool of substrates. An important aspect of bacterial CL synthesis is that it is a reversible reaction depending on substrate availability and product requirement [35, 45]. Thus, PLD-type Cls might also be involved in CL degradation and turnover. It is therefore possible, that while both A. tumefaciens Cls1 and Cls2 make use of the same pool of substrates, they might differ in their role in CL formation and turnover.
Contribution of Cls1 and Cls2 to CL production is growth phase-dependent
The amount of CL in the membranes can significantly vary during the cell cycle as a consequence of increased or decreased Cls activity or accelerated CL turnover [14, 46–48]. We therefore compared CL formation of A. tumefaciens wild type and the cls mutant strains at different optical densities via 1D-TLC (Fig 5A). The relative CL content increased in a growth-phase dependent manner in the wild type and the Δcls single deletion strains (Fig 5B). The double mutant lacked detectable CL regardless of the growth phase (Fig 5A), confirming that Cls1 and Cls2 are primarily responsible for CL formation in A. tumefaciens. It is striking that CL levels in the Δcls2 strain did not increase until growth exceeded the logarithmic growth phase, suggesting that Cls1 cannot compensate for the absence of Cls2 at early stationary phase. This distinct contribution of Cls1 and Cls2 to CL synthesis dependent on growth phase suggests differences in their role and regulation and might be attributed to different transcriptional or enzymatic activities.
The cls1 and cls2 genes are constitutively expressed
To test whether the growth phase-dependent accumulation of CL mediated by Cls1 and Cls2 is reflected by differential expression, we constructed translational cls1- and cls2-lacZ fusions. In the wild type, expression of both cls-lacZ fusions was constitutive and completely independent of the growth phase (Fig 6). Overall expression of cls1 was higher than expression of cls2 under all tested conditions. Deletion of either cls1 or cls2 did not affect expression of the remaining cls (data not shown). The constitutive expression of both cls genes suggests that growth phase-dependent control of CL biosynthesis occurs at the post-transcriptional level. Likewise, accumulation of CL in the stationary phase in E. coli is attributed to changes in ClsA activity whereas clsA expression remains at a constant level throughout growth. Additionally, the stationary phase increase in ClsA activity was irrespective of the phospholipid environment, as is the case in strains lacking pssA1 (encoding for a temperature-sensitive phosphatidylserine synthase) and pgsA3 (encoding for phosphatidylglycerol-phosphate synthase) [47]. Different contribution of two Cls enzymes in CL homeostasis has also been reported in S. aureus. Here, CL accumulation in stationary phase and after phagocytosis is caused by the activity of Cls2 rather than Cls1 and might be caused by different regulation of cls1 and cls2 mRNA synthesis and/or turnover [14].
In many bacteria, CL accumulates in response to osmotic stress [2, 46]. Thus, we checked whether cls1 and cls2 expression or CL accumulation is affected by high salt concentrations in A. tumefaciens. Neither expression of cls1 and cls2 (data not shown) nor CL production were influenced under osmotic stress conditions (S3 Fig). Thus, CL accumulation is not regulated by osmotic stress in A. tumefaciens.
Cls2 utilizes PG for CL formation in vitro
Since Cls1/2 purification from E. coli failed, we aimed to characterize the activity and substrate specificity of the Cls1 and Cls2 enzymes by assaying their activities in crude extracts of A. tumefaciens wild type and cls deletion strains. Cell lysates of the strains were supplemented with commercially available potential lipid substrates (PG, PE or CDP-DAG) alone or in combination, and reaction products were isolated and analyzed via 1D-TLC. PE or CDP-DAG were not converted to CL under all tested conditions (data not shown). Remarkably, the CL content increased only when reaction mixture with wild type or Δcls1 cell lysates were supplemented with PG (Fig 7A and 7B). PG-dependent increase of CL was not detected in Δcls2 or Δcls1/Δcls2 lysates suggesting that PG-dependent CL accumulation is mediated by Cls2. Although accumulation of PG in the double cls mutant but not in the single mutants (Fig 4A) indicated that both enzymes might utilize PG as substrate, a conversion of external PG to CL by Cls1 was not detectable (Fig 7). Differences in PG-species selectivity or requirement of specific cofactor(s) might account for these differences. It has been proposed that CL formation by PLD-type Cls is a reversible reaction. Degradation of CL by PLD-type Cls enzymes is dependent on substrate availability and product requirement [45]. Under our tested conditions, there was no evidence for turnover of the supplied CL.
CL is not required for basic cellular processes and tumorigenesis in A. tumefaciens
Anionic phospholipids, like CL and PG, are crucial for cell cycle, osmotic stress and cell morphology in different bacteria [3, 10, 11, 46]. To determine the physiological role of CL in A. tumefaciens, we conducted experiments addressing the viability of the CL-deficient mutant strain. Loss of CL did not affect growth in rich or minimal medium (Fig 8A). Neither the absence of CL, nor the deletion of either cls1 or cls2 impaired biofilm formation or motility (data not shown). Notably, growth of the Δcls1/Δcls2 strain under UV-stress, at elevated or decreased temperatures and in the absence or presence of up to 0.4 M sodium chloride was not compromised (data not shown) suggesting that CL is not required for survival of A. tumefaciens under those conditions. We have previously shown that A. tumefaciens lacking PC exhibits severe defects in tumorigenesis, which is due to the absence of the membrane-spanning type IV secretion system (T4SS) [18, 49]. To investigate whether CL is also involved in pathogenicity, we monitored the presence of VirB8 and VirB9, which are components of the T4SS (Fig 8B). In the wild type and the CL-deficient mutant, both VirB8 and VirB9 were detected after treatment with the artificial virulence inductor acetosyringone (+ vir), demonstrating that CL, in contrast to PC, is not necessary for the synthesis of the T4SS. Tumorigenesis studies on potato discs further revealed that the CL-deficient mutant is not impaired in tumor formation (Fig 8C). In contrast, contribution of CL to virulence has been demonstrated in a number of human pathogens such as Moraxella catarrhalis, S. aureus and Salmonella enterica [10, 31, 50, 51].
A recent study revealed that CL deficiency in R. sphaeroides leads to defects in biofilm formation and produces ellipsoidal-shaped cells, while growth remained unaffected [11]. Likewise, a Pseudomonas putida cls mutant is smaller in size compared to wild-type cells and exhibits increased sensitivity to several antibiotics but displays no growth defect [52]. However, cell shape or size of the CL-deficient strain was unaffected (data not shown) suggesting a negligible role of CL in cell morphology in A. tumefaciens.
Loss of CL in A. tumefaciens is accompanied by increased PG levels. Like CL, PG is an anionic phospholipid contributing to membrane potential and stability in different organisms [53]. CL deficiency in E. coli is accompanied by increased PG levels at the cell poles compensating the anionic and polar function of CL in the membrane [8]. Thus, it is tempting to believe that elevated amounts of PG compensate for the lacking CL in the Δcls1/Δcls2 strain.
The present study was intended to understand metabolic pathways and physiological relevance of CL in A. tumefaciens. We showed that A. tumefaciens harbors two distinctly regulated PLD-type enzymes responsible for CL formation. Loss of CL was not accompanied by obvious phenotypic changes. In contrast to many other bacteria, A. tumefaciens seems to be more flexible in accommodating CL loss. Contrary to these bacteria, Agrobacterium membranes are characterized by a complex lipid composition including additional lipids such as MMPE, DMPE, PC and two ornithine lipids, which may compensate the loss of CL. The hydroxyl bound fatty acids in both ornithine lipids in A. tumefaciens contain almost exclusively a 19:0 cyclopropanted fatty acid [17, 20]. Similar to CL, membrane lipids containing cyclopropanated fatty acids are proposed to increase membrane fluidity [54, 55]. Thus, it is conceivable that the OLs in A. tumefaciens might compensate the function of CL in maintaining membrane fluidity. Furthermore, Vences-Guzman et al. showed that the relative amount of the head-group hydroxylated OL2 increases at lower growth temperature supporting a role of OL2 in membrane fluidity [20].
Supporting Information
Acknowledgments
We thank Robbin Stantscheff and Sonja Klüsener for the construction of pBO1256, pBO1270 and pBO1271. We are grateful to Christian Baron for providing us with VirB-specific antisera and to Peter Dörmann for GC/MS analysis of membrane lipids. We also thank Franz Narberhaus and Bernd Masepohl for critical reading of the manuscript and for valuable suggestions.
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
The authors received no specific funding for this work.
References
- 1.Renner LD, Weibel DB. Cardiolipin microdomains localize to negatively curved regions of Escherichia coli membranes. Proc Natl Acad Sci U S A. 2011;108(15):6264–6269. 10.1073/pnas.1015757108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Romantsov T, Helbig S, Culham DE, Gill C, Stalker L, Wood JM. Cardiolipin promotes polar localization of osmosensory transporter ProP in Escherichia coli. Mol Microbiol. 2007;64(6):1455–1465. 10.1111/j.1365-2958.2007.05727.x [DOI] [PubMed] [Google Scholar]
- 3.Romantsov T, Guan Z, Wood JM. Cardiolipin and the osmotic stress responses of bacteria. Biochim Biophys Acta. 2009;1788(10):2092–2100. 10.1016/j.bbamem.2009.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pfeiffer K, Gohil V, Stuart RA, Hunte C, Brandt U, Greenberg ML, et al. Cardiolipin stabilizes respiratory chain supercomplexes. J Biol Chem. 2003;278(52):52873–52880. 10.1074/jbc.M308366200 [DOI] [PubMed] [Google Scholar]
- 5.Nichols-Smith S, Teh SY, Kuhl TL. Thermodynamic and mechanical properties of model mitochondrial membranes. Biochim Biophys Acta. 2004;1663(1–2):82–88. 10.1016/j.bbamem.2004.02.002 [DOI] [PubMed] [Google Scholar]
- 6.Mileykovskaya E, Dowhan W. Visualization of phospholipid domains in Escherichia coli by using the cardiolipin-specific fluorescent dye 10-N-nonyl acridine orange. J Bacteriol. 2000;182(4):1172–1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kawai F, Shoda M, Harashima R, Sadaie Y, Hara H, Matsumoto K. Cardiolipin domains in Bacillus subtilis marburg membranes. J Bacteriol. 2004;186(5):1475–1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Oliver PM, Crooks JA, Leidl M, Yoon EJ, Saghatelian A, Weibel DB. Localization of anionic phospholipids in Escherichia coli cells. J Bacteriol. 2014;196(19):3386–3398. 10.1128/JB.01877-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Lobasso S, Palese LL, Angelini R, Corcelli A. Relationship between cardiolipin metabolism and oxygen availability in Bacillus subtilis. FEBS Open Bio. 2013;3:151–155. 10.1016/j.fob.2013.02.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Tsai M, Ohniwa RL, Kato Y, Takeshita SL, Ohta T, Saito S, et al. Staphylococcus aureus requires cardiolipin for survival under conditions of high salinity. BMC Microbiol. 2011;11:13 10.1186/1471-2180-11-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lin TY, Santos TM, Kontur WS, Donohue TJ, Weibel DB. A cardiolipin-deficient mutant of Rhodobacter sphaeroides has an altered cell shape and is impaired in biofilm formation. J Bacteriol. 2015; 10.1128/JB.00420-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tian HF, Feng JM, Wen JF. The evolution of cardiolipin biosynthesis and maturation pathways and its implications for the evolution of eukaryotes. BMC Evol Biol. 2012;12:32 10.1186/1471-2148-12-32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tan BK, Bogdanov M, Zhao J, Dowhan W, Raetz CR, Guan Z. Discovery of a cardiolipin synthase utilizing phosphatidylethanolamine and phosphatidylglycerol as substrates. Proc Natl Acad Sci U S A. 2012;109(41):16504–16509. 10.1073/pnas.1212797109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Koprivnjak T, Zhang D, Ernst CM, Peschel A, Nauseef WM, Weiss JP. Characterization of Staphylococcus aureus cardiolipin synthases 1 and 2 and their contribution to accumulation of cardiolipin in stationary phase and within phagocytes. J Bacteriol. 2011;193(16):4134–4142. 10.1128/JB.00288-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sandoval-Calderón M, Geiger O, Guan Z, Barona-Gómez F, Sohlenkamp C. A eukaryote-like cardiolipin synthase is present in Streptomyces coelicolor and in most actinobacteria. J Biol Chem. 2009;284(26):17383–17390. 10.1074/jbc.M109.006072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Moser R, Aktas M, Fritz C, Narberhaus F. Discovery of a bifunctional cardiolipin/phosphatidylethanolamine synthase in bacteria. Mol Microbiol. 2014;92(5):959–972. 10.1111/mmi.12603 [DOI] [PubMed] [Google Scholar]
- 17.Geske T, Vom Dorp K, Dörmann P, Hölzl G. Accumulation of glycolipids and other non-phosphorous lipids in Agrobacterium tumefaciens grown under phosphate deprivation. Glycobiology. 2013;23(1):69–80. 10.1093/glycob/cws124 [DOI] [PubMed] [Google Scholar]
- 18.Wessel M, Klüsener S, Gödeke J, Fritz C, Hacker S, Narberhaus F. Virulence of Agrobacterium tumefaciens requires phosphatidylcholine in the bacterial membrane. Mol Microbiol. 2006;62(3):906–915. 10.1111/j.1365-2958.2006.05425.x [DOI] [PubMed] [Google Scholar]
- 19.Zambryski P, Tempe J, Schell J. Transfer and function of T-DNA genes from Agrobacterium Ti and Ri plasmids in plants. Cell. 1989;56(2):193–201. [DOI] [PubMed] [Google Scholar]
- 20.Vences-Guzmán MA, Guan Z, Bermúdez-Barrientos JR, Geiger O, Sohlenkamp C. Agrobacteria lacking ornithine lipids induce more rapid tumour formation. Environ Microbiol. 2013;15(3):895–906. 10.1111/j.1462-2920.2012.02867.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sambrook JRD. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press; 2001. [Google Scholar]
- 22.Schmidt-Eisenlohr H, Domke N, Angerer C, Wanner G, Zambryski PC, Baron C. Vir proteins stabilize VirB5 and mediate its association with the T pilus of Agrobacterium tumefaciens. J Bacteriol. 1999;181(24):7485–7492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911–917. [DOI] [PubMed] [Google Scholar]
- 24.Devers EA, Wewer V, Dombrink I, Dörmann P, Hölzl G. A processive glycosyltransferase involved in glycolipid synthesis during phosphate deprivation in Mesorhizobium loti. J Bacteriol. 2011;193(6):1377–1384. 10.1128/JB.00768-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Tsai YL, Wang MH, Gao C, Klüsener S, Baron C, Narberhaus F, et al. Small heat-shock protein HspL is induced by VirB protein(s) and promotes VirB/D4-mediated DNA transfer in Agrobacterium tumefaciens. Microbiology. 2009;155(Pt 10):3270–3280. 10.1099/mic.0.030676-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Miller JH. Experiments in molecular genetics Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press; 1972. [Google Scholar]
- 27.Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539 10.1038/msb.2011.75 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Hirschberg CB, Kennedy EP. Mechanism of the enzymatic synthesis of cardiolipin in Escherichia coli. Proc Natl Acad Sci U S A. 1972;69(3):648–651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Koonin EV. A duplicated catalytic motif in a new superfamily of phosphohydrolases and phospholipid synthases that includes poxvirus envelope proteins. Trends Biochem Sci. 1996;21(7):242–243. [PubMed] [Google Scholar]
- 30.Ponting CP, Kerr ID. A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues. Protein Sci. 1996;5(5):914–922. 10.1002/pro.5560050513 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Buskirk SW, Lafontaine ER. Moraxella catarrhalis expresses a cardiolipin synthase that impacts adherence to human epithelial cells. J Bacteriol. 2014;196(1):107–120. 10.1128/JB.00298-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Stuckey JA, Dixon JE. Crystal structure of a phospholipase D family member. Nat Struct Biol. 1999;6(3):278–284. 10.1038/6716 [DOI] [PubMed] [Google Scholar]
- 33.Krogh A, Larsson B, von Heijne G, Sonnhammer EL. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001;305(3):567–580. 10.1006/jmbi.2000.4315 [DOI] [PubMed] [Google Scholar]
- 34.Sonnhammer EL, von Heijne G, Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol. 1998;6:175–182. [PubMed] [Google Scholar]
- 35.Shibuya I, Yamagoe S, Miyazaki C, Matsuzaki H, Ohta A. Biosynthesis of novel acidic phospholipid analogs in Escherichia coli. J Bacteriol. 1985;161(2):473–477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Heber S, Tropp BE. Genetic regulation of cardiolipin synthase in Escherichia coli. Biochim Biophys Acta. 1991;1129(1):1–12. [DOI] [PubMed] [Google Scholar]
- 37.Davlieva M, Zhang W, Arias CA, Shamoo Y. Biochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci. Antimicrob Agents Chemother. 2013;57(1):289–296. 10.1128/AAC.01743-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Guo D, Tropp BE. A second Escherichia coli protein with CL synthase activity. Biochim Biophys Acta. 2000;1483(2):263–274. [DOI] [PubMed] [Google Scholar]
- 39.Quigley BR, Tropp BE. E. coli cardiolipin synthase: function of N-terminal conserved residues. Biochim Biophys Acta. 2009;1788(10):2107–2113. 10.1016/j.bbamem.2009.03.016 [DOI] [PubMed] [Google Scholar]
- 40.Kim KS, Manasherob R, Cohen SN. YmdB: a stress-responsive ribonuclease-binding regulator of E. coli RNase III activity. Genes Dev. 2008;22(24):3497–3508. 10.1101/gad.1729508 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Das P, Basu M, Chatterjee G. Lipid profile of the strains of Agrobacterium tumefaciens in relation to agrocin resistance. J Gen Appl Microbiol. 1979;25(1):5–9. 10.2323/jgam.25.1 [DOI] [Google Scholar]
- 42.Zhang X, Tamot B, Hiser C, Reid GE, Benning C, Ferguson-Miller S. Cardiolipin deficiency in Rhodobacter sphaeroides alters the lipid profile of membranes and of crystallized cytochrome oxidase, but structure and function are maintained. Biochemistry. 2011;50(19):3879–3890. 10.1021/bi101702c [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Chang SC, Heacock PN, Mileykovskaya E, Voelker DR, Dowhan W. Isolation and characterization of the gene (CLS1) encoding cardiolipin synthase in Saccharomyces cerevisiae. J Biol Chem. 1998;273(24):14933–14941. [DOI] [PubMed] [Google Scholar]
- 44.MacGilvray ME, Lapek JD Jr., Friedman AE, Quivey RG Jr. Cardiolipin biosynthesis in Streptococcus mutans is regulated in response to external pH. Microbiology. 2012;158(Pt 8):2133–2143. 10.1099/mic.0.057273-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Schlame M. Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes. J Lipid Res. 2008;49(8):1607–1620. 10.1194/jlr.R700018-JLR200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.López CS, Alice AF, Heras H, Rivas EA, Sánchez-Rivas C. Role of anionic phospholipids in the adaptation of Bacillus subtilis to high salinity. Microbiology. 2006;152(Pt 3):605–616. 10.1099/mic.0.28345-0 [DOI] [PubMed] [Google Scholar]
- 47.Hiraoka S, Matsuzaki H, Shibuya I. Active increase in cardiolipin synthesis in the stationary growth phase and its physiological significance in Escherichia coli. FEBS Lett. 1993;336(2):221–224. [DOI] [PubMed] [Google Scholar]
- 48.Cronan JE Jr. Phospholipid alterations during growth of Escherichia coli. J Bacteriol. 1968;95(6):2054–2061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Klüsener S, Aktas M, Thormann KM, Wessel M, Narberhaus F. Expression and physiological relevance of Agrobacterium tumefaciens phosphatidylcholine biosynthesis genes. J Bacteriol. 2009;191(1):365–374. 10.1128/JB.01183-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Dalebroux ZD, Matamouros S, Whittington D, Bishop RE, Miller SI. PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane. Proc Natl Acad Sci U S A. 2014;111(5):1963–1968. 10.1073/pnas.1316901111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Dalebroux ZD, Edrozo MB, Pfuetzner RA, Ressl S, Kulasekara BR, Blanc MP, et al. Delivery of cardiolipins to the Salmonella outer membrane is necessary for survival within host tissues and virulence. Cell Host Microbe. 2015;17(4):441–451. 10.1016/j.chom.2015.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Bernal P, Munoz-Rojas J, Hurtado A, Ramos JL, Segura A. A Pseudomonas putida cardiolipin synthesis mutant exhibits increased sensitivity to drugs related to transport functionality. Environ Microbiol. 2007;9(5):1135–1145. 10.1111/j.1462-2920.2006.01236.x [DOI] [PubMed] [Google Scholar]
- 53.Tari A, Huang L. Structure and function relationship of phosphatidylglycerol in the stabilization of the phosphatidylethanolamine bilayer. Biochemistry. 1989;28(19):7708–7712. [DOI] [PubMed] [Google Scholar]
- 54.Unsay JD, Cosentino K, Subburaj Y, Garcia-Saez AJ. Cardiolipin effects on membrane structure and dynamics. Langmuir. 2013;29(51):15878–15887. 10.1021/la402669z [DOI] [PubMed] [Google Scholar]
- 55.Poger D, Mark AE. A ring to rule them all: the effect of cyclopropane Fatty acids on the fluidity of lipid bilayers. J Phys Chem B. 2015;119(17):5487–5495. 10.1021/acs.jpcb.5b00958 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.